It's time, page-31

Hello to the Cynata tribe.
Good news will follow the fundamentals of this company at some point at a time none of us know. There are very few (and I mean low single-digit) companies in the world that have the key foundation stones that Cynata has. More interesting is the lack of companies that have been able to access commercial rights to iPSCs since 2011 for therapeutic products. And then critically, have you noticed how the Japanese companies are building their critical-mass in this field. Lets imagine Cynata has the most potent MSCs yet seen, derived from iPSCs with unlimited scale, has world-wide commercial use of iPSCs under license and the Japanese are on a buying-spree. And we are all getting older and need regenerative medicines yesterday. Mmmm. Looks like a winner to me. The questions are when and how much. None of us know that yet. Does day follow night ?